1.
Parra Serrano GA, Torres Langhammer MP, Pinto Arias AJ, Serrano-Gómez S. Effectiveness of IDegLira in Type-2 Diabetes Patients During the COVID-19 Pandemic: A Teleconsultation Follow-up. Rev.ACE [Internet]. 2022 Oct. 19 [cited 2024 Mar. 29];9(4). Available from: https://revistaendocrino.org/index.php/rcedm/article/view/740